Updated ADQI Guidelines for AKI in Cirrhosis Assessment and Management of HRS/AKI in the ICU-Key Information From ADQI Expert Consensus Guidelines on AKI in Cirrhosis

Key Information From ADQI Expert Consensus Guidelines on AKI in Cirrhosis

Video Transcription

Video Summary

The talk summarizes outcomes from the AdKey International Club of Societies Consensus meeting on AKI and cirrhosis. Key points include redefining diagnostic criteria for hepatorenal syndrome, emphasizing urine output as a diagnostic tool, and reconsidering 48-hour albumin administration. Personalized AKI management based on health profiles and fluid resuscitation protocols, such as using crystalloids, were recommended. The importance of timely vasoconstrictor therapy like Turlopressin and the need for liver transplant evaluation for sustained recovery were highlighted. The focus was on refining approaches to assess AKI, manage volume status, and improve treatment outcomes.

Keywords

AKI

cirrhosis

hepatorenal syndrome

vasoconstrictor therapy

liver transplant

	Society of Critical Care Medicine 500 Midway Drive Mount Prospect, IL 60056 USA Phone: +1 847 827-6888 Fax: +1 847 439-7226 Email: support@sccm.org	Contact Us About SCCM Newsroom Advertising & Sponsorship DONATE	MySCCM LearnICU Patients & Families Surviving Sepsis Campaign Critical Care Societies Collaborative	GET OUR NEWSLETTER
© Society of Critical Care Medicine. All rights reserved. \| Privacy Statement \| Terms & Conditions The Society of Critical Care Medicine, SCCM, and Critical Care Congress are registered trademarks of the Society of Critical Care Medicine.